跳至主要内容
临床试验/PACTR2010020001429343
PACTR2010020001429343Other未知

EVALUATION OF THE SAFETY AND EFFICACY OF MEFLOQUINE AS INTERMITTENT PREVENTIVE TREATMENT FOR MALARIA IN PREGNANCY

FCRB0 个研究点目标入组 0 人开始时间: 2009年5月27日最近更新:
适应症

试验速览

阶段
未知
状态
Other
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 Year(s) 至 50 Year(s)(—)
性别
Female

入选标准

  • Permanent resident in the area
  • Gestational age at the first antenatal visit < 28 weeks
  • Signed informed consent
  • Agreement to deliver in the study site's maternity wards

排除标准

  • Residence outside the study area or planning to move out in the following 18 months from enrollment
  • Gestational age at the first antenatal visit > 28 weeks of pregnancy
  • Known history of allergy to sulfa drugs or mefloquine
  • Known history of severe renal, hepatic, psychiatric or neurological disease
  • MQ or halofantrine treatment in the preceding 4 weeks
  • HIV infection
  • Participating in other studies

研究者

发起方
FCRB

相似试验